Previous Close | 16.50 |
Open | 16.50 |
Bid | 14.85 |
Ask | 15.45 |
Strike | 560.00 |
Expire Date | 2025-01-17 |
Day's Range | 16.50 - 16.50 |
Contract Range | N/A |
Volume | |
Open Interest | 465 |
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eli Lilly (LLY) enjoys strong fundamentals and is expected to consistently do well, mainly supported by its new drugs and its solid pipeline.